Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
A randomized trial of classical and medium-chain triglyceride ketogenic diets in the treatment of childhood epilepsy
A Claims-Based Study of 30,458 Patients A retrospective cohort study using insurance claims and electronic health records compared 14,101 bariatric surgery patients (mean follow-up 34 months) against 16,357 GLP-1 patients (mean follow-up 32 months), all with class II or III obesity
Chemical and physical properties of Tirzepatide Drug Target Tirzepatide is a dual agonist for both GLP-1 and GIP receptors
FIGURE 4 Utilization of VPA in pediatric patients and related risks The findings indicate that the underage population exhibited certain protective effects in both monotherapy and multidrug combination therapy
For many patients, this may prove the optimal long-term dose
US$ 23.68
US$ 22.80
US$ 21.81
US$ 22.27
US$ 23.29
US$ 21.14
US$ 22.30
US$ 27.28
US$ 26.02
US$ 27.61
US$ 20.32
